52 results
NT 10-K
MIRM
Mirum Pharmaceuticals Inc
28 Feb 24
Notice of late annual filing
5:01pm
and it is the first year that the Company’s auditor has been required to attest to, and report on, management’s assessment of the Company’s internal control
8-K/A
EX-99.4
egsourwgohroe1u
2 Nov 23
Financial Statements and Exhibits
4:05pm
8-K
EX-99.1
lxqk7h 96jqoe
13 Oct 23
Other Events
4:16pm
8-K
EX-2.1
wwke7
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-10.1
e1o5fgkck x5w65
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
S-3ASR
EX-4.3
08oow1cy0l0gsu
9 Sep 22
Automatic shelf registration
4:31pm
8-K
EX-1.1
n7bhgz4i7fin7
10 Aug 22
Other Events
12:00am